Glutamic Acid Decarboxylase Injection Into Lymph Nodes: Beta Cell Function and Immune Responses in Recent Onset Type 1 Diabetes Patients

Glutamic Acid Decarboxylase Injection Into Lymph Nodes: Beta Cell Function and Immune Responses in Recent Onset Type 1 Diabetes Patients

In spite of intensive treatment Type 1 diabetes leads to serious complications. Preservation of residual beta cell function makes the disease milder, facilitates treatment, prevents complications and increase survival. So far immune interventions have had limited effect, and some serious adverse eve...

Full description

Bibliographic Details
Main Authors: Rosaura Casas, Fabrícia Dietrich, Hugo Barcenilla, Beatriz Tavira, Jeanette Wahlberg, Peter Achenbach, Johnny Ludvigsson
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-10-01
Series:Frontiers in Immunology
Subjects:
autoantigen
immunotherapy
GAD-alum
type 1 diabetes
Vitamin D
intra-lymphatic treatment
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2020.564921/full

Internet

https://www.frontiersin.org/article/10.3389/fimmu.2020.564921/full

Similar Items